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Study objectives
Assess the range of starting T cell percentage in the
CTL019 expansion process.
Results
The current CTL019 process targets 450e9 total nucleated
cells (TNC) at seeding of the static culture bags prior to
activation and transduction (Kalos M et al. 2011; Maude
et al. 2014). However, less is known on the impact of a
range of T cell numbers within the TNC population on,
transduction efficiency and expansion. Healthy donor
T cells cultures were evaluated in the range of the starting
T cell percentages between 1.7% and 97.7%. T cells
expanded in all tested conditions with the population dou-
bling range between 3.7 and 8.5, and the percentages of
T cells at the end of the culture period were 94.9 ± 5.0%.
The major non-target cell population at the end of culture
was NK cell population (4.8 % ± 2.9%).
The feasibility of expanding T cells from leukemic
donors with very low T cell content was assessed on
three ALL patient samples with original T cell contents
of 1.4%, 1.2% and 2.0%. After polyclonal stimulation and
growth in culture T cell percentages were respectively
the following: 78.1%, 95.9% and 1.1% (non-expander),
supporting the potential of some ALL patients with low
T cell counts to meet cell number requirements after
9 day expansion for cell therapy in the absence of T cell
enrichment steps.
Conclusions
Healthy donor T cells can be used to assess the impact of
low percentage T cell number in the CTL019 manufactur-
ing process. These studies support the use of low T cell
percentages as starting material for the CTL019 process.
However, the impact on the final product, e.g. transduc-
tion efficiency, has to be further evaluated. Finally, in case
of the ALL patients, the outcome can be different between
donors.
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